How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.
Lorna Rothery spoke to Health Care Without Harm (HCWH) Europe about the impact of pharmaceutical pollution and the barriers that need to be overcome to achieve a greener, more sustainable industry.
Ewan Townsend, Co-chair of Arnold & Porter’s Sustainability Committee, discusses the pharmaceutical sector’s shift towards environmentally friendly green chemistry.
Despite the growing burden of mental health problems, there remains a significant unmet medical need. Tadeusz Hawrot, Founder and Executive Director at Parea tells us why new treatments are urgently needed and how psychedelic therapy and medicines can help
Kate Fry, CEO of America’s Blood Centers, discusses the essential role of blood products and transfusion medicine in the U.S. and the efforts to ensure blood’s safety and availability.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes how tackling wasted medicines is crucial to achieving sustainable healthcare.
Blockchain wasn’t invented as a supply management tool; yet, today it is helping to solve some of the most complex problems existing in global supply chains.
Cardiac health and AI: A momentous collaboration between healthcare organizations in the UK and the US unveils the Veterans Cardiac Health and AI Model Predictions (V-CHAMPs) Challenge.
Medical breakthroughs are quickly being accessed through a ground-breaking initiative, providing manufacturers and innovators with all-encompassing collaborative support.
Harrison Thomas, the Content Marketing Executive at CoolMed, discusses what the healthcare industry should consider when purchasing a medical fridge or freezer.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes how integrating clinical, cost, and carbon effectiveness is key to delivering sustainable healthcare with the Triple-C framework.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes why digital medicine information is essential for sustainable medicines.
A survey looking at ayahuasca dangers finds 70% experience physical and 55% mental health adverse effects – but only 2.3% of physical adverse events require medical attention.
